As winter approaches, health officials in Wisconsin are strongly encouraging residents to receive vaccinations against several respiratory illnesses, notably COVID-19. This recommendation comes as many individuals face confusion regarding access to COVID shots amid evolving guidelines.
The Wisconsin Department of Health Services (DHS) noted that respiratory illnesses tend to surge in the fall. Although current illness levels are relatively low, officials emphasize the importance of early vaccination for flu, COVID-19, and RSV (respiratory syncytial virus). Tom Haupt, a respiratory disease epidemiologist with DHS, cautioned that it may take up to two weeks for vaccines to offer full protection against these viruses.
“Vaccines not only protect the individual but also help curb the spread of viruses, which is vital for safeguarding vulnerable populations,” Haupt said.
Last winter, Wisconsin experienced one of its most challenging flu seasons in recent years, with approximately 7,000 hospitalizations linked to seasonal flu complications. Tragically, the flu claimed the lives of more than 280 children nationally, including five cases reported in Wisconsin.
Reports have highlighted that some Wisconsin parents encountered difficulties accessing COVID-19 vaccinations for their children. This confusion has sparked concerns following alterations in federal recommendations regarding eligibility for the COVID-19 vaccine.
Wisconsin’s Immunization Program Manager, Stephanie Schauer, acknowledged these hurdles but remains optimistic about improving accessibility as providers receive more vaccines. In a recent change, the FDA limited COVID-19 vaccinations to individuals aged 65 and older or those considered at high risk. The new guidelines were sanctioned by the CDC, following a review by members of the Advisory Committee on Immunization Practices.
Despite these challenges, Wisconsin health officials advocate for universal vaccination against COVID-19 for everyone over six months old. Schauer indicated that current vaccination levels may be lagging compared to previous years, yet she expressed hope for increased uptake as awareness grows.
The COVID-19 virus poses serious health risks, and the newly authorized vaccine is designed to protect against circulating strains. Schauer pointed out that a significant portion of children hospitalized with COVID-19 last year had no underlying health issues.
Regarding the flu, Haupt noted last year’s severity may have been influenced by both lower vaccination rates and the presence of a more virulent strain. Ongoing research aims to better understand these factors, with the hope that higher vaccination rates this year will lead to better outcomes.
In recent weeks, the state has reported an uptick in hospitalizations related to COVID-19 and influenza, alongside some RSV cases, particularly among older adults. Typical flu symptoms—high fever, body aches, coughing—can mirror those of COVID-19, highlighting the necessity of accurate testing. Antiviral treatments are available for both illnesses.
RSV, primarily affecting young children, presents with symptoms like coughing and could lead to bronchitis. A new vaccine for RSV is now accessible for individuals over 50, while infants and those 50 and older can also receive vaccinations against pneumococcal pneumonia, a common flu complication.
Health officials have confirmed that it is safe to receive all these vaccines simultaneously. As late November and December approach, the state anticipates a significant rise in flu and COVID-19 cases, making timely vaccination even more crucial for community health.